Clinical applications of exercise in Parkinson's disease: what we need to know?


Journal

Expert review of neurotherapeutics
ISSN: 1744-8360
Titre abrégé: Expert Rev Neurother
Pays: England
ID NLM: 101129944

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 29 9 2022
medline: 2 11 2022
entrez: 28 9 2022
Statut: ppublish

Résumé

Exploring the potential of exercise in the rehabilitation process of patients with Parkinson's (PD) may be an interesting treatment perspective. Exercise-induced responses derived from neurotrophic elements appear to ameliorate the decline in neurodegeneration. Despite this understanding, the literature needs to be updated. Our review focuses on: a) the key mechanisms of exercise on PD, highlighting mainly the responses related to neuroplasticity; b) the effects induced by different traditional types of exercise, also highlighting the effects of complementary therapies related to movement; c) the volume of exercise required to support efficient results are explored in the context of PD. Additionally, the proposition of new clinical application strategies in the context of PD will also be determined. It is suggested that different intensities of aerobic exercise be explored for the treatment of PD. The results associated with high intensity seem promising for performance, physiological and clinical parameters, such as BDNF production and cognition. On the other hand, the diversification of tasks and repetition of motor gestures appear as consistent arguments to exercise prescription. Finally, for future investigations, the neuromodulation strategy in association with aerobic exercise appears as a potential inducer of benefits on gait and cognitive function.

Identifiants

pubmed: 36168890
doi: 10.1080/14737175.2022.2128768
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

771-780

Auteurs

Sergio Machado (S)

Department of Sports Methods and Techniques, Federal University of Santa Maria, Santa Maria, Brazil.
Physical Activity Neuroscience Laboratory (LABNAF), Neurodiversity Institute, Queimados-RJ, Brazil.
Intercontinental Neuroscience Research Group, Mérida, Mexico.

Diogo Teixeira (D)

Universidade Lusófona, Faculty of Physical Education and Sport, Lisbon, Portugal; Research Center in Sport, Physical Education, and Exercise and Health (CIDEFES), Lisbon, Portugal.

Diogo Monteiro (D)

ESECS, Polytechnic of Leiria, 2411-901 Leiria, Portugal; Research Center in Sport, Health and Human Development (CIDESD), 5000-558, Vila Real, Portugal.
Life Quality Research Centre (CIEQV), Leiria, Portugal.

Claudio Imperatori (C)

Intercontinental Neuroscience Research Group, Mérida, Mexico.
Cognitive and Clinical Psychology Laboratory, Department of Human Sciences European University of Rome, Rome, Italy.

Eric Murillo-Rodriguez (E)

Intercontinental Neuroscience Research Group, Mérida, Mexico.
Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, División Ciencias de la Salud, Universidad Anáhuac Mayab, Mexico.

Fernanda Pereira da Silva Rocha (FP)

Postgraduate Program in Human Movement and Rehabilitation, Evangelia University of Goiás, Anápolis, Brazil.

Tetsuya Yamamoto (T)

Intercontinental Neuroscience Research Group, Mérida, Mexico.
Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan.

Sandra Amatriain-Fernández (S)

Institute for Systems Medicine (ISM) at the Faculty of Human Sciences, Medical School Hamburg, Hamburg, Germany.

Henning Budde (H)

Intercontinental Neuroscience Research Group, Mérida, Mexico.
Institute for Systems Medicine (ISM) at the Faculty of Human Sciences, Medical School Hamburg, Hamburg, Germany.

Mauro Giovanni Carta (MG)

Dipartimento di Sanità Pubblica, Università degli studi di Cagliari, Cagliari, Italy.

Leonardo Caixeta (L)

Neurology and Neuropsychiatry Department of Clinical Medicine, Federal University of Goiás, School of Medicine, Goiânia, Brazil.

Alberto Souza de Sá Filho (AS)

Intercontinental Neuroscience Research Group, Mérida, Mexico.
Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, División Ciencias de la Salud, Universidad Anáhuac Mayab, Mexico.
Department of Physical Education, Paulista University, Goiânia, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH